A$19.26
1.86%
Australia, Sep 18, 12:41 pm AEST. Market open.
ISIN
AU000000SHL7
Symbol
SHL

Sonic Healthcare Target price 2026 - Analyst rating & recommendation

Sonic Healthcare Classifications & Recommendation

Buy
14%
Hold
55%
Sell
32%

Sonic Healthcare Price Target

Target Price A$22.64
Price A$19.62
Potential
Number of Estimates 17
17 Analysts have issued a price target Sonic Healthcare 2027 . The average Sonic Healthcare target price is A$22.64. This is higher than the current stock price. The highest price target is , the lowest is .
A rating was issued by 22 analysts: 3 Analysts recommend Sonic Healthcare to buy, 12 to hold and 7 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the Sonic Healthcare stock has an average upside potential 2027 of . Most analysts recommend the Sonic Healthcare stock at Hold.

Sales and Margin forecast 2026, 2027 to 2033

Create a premium account to unlock analyst estimates. Learn more

Select at least one metric to display the chart.


Jun '25 2026
Estimates
Revenue Billion A$ 9.65 10.98
7.56% 13.87%
EBITDA Margin 18.11% 17.63%
0.18% 2.65%
Net Margin 5.32% 5.47%
6.57% 2.73%

17 Analysts have issued a sales forecast Sonic Healthcare 2026 . The average Sonic Healthcare sales estimate is

A$11.0b
unlock
. This is
5.38% higher
unlock
than the revenue of the last 12 months(TTM). The highest sales forecast is
A$11.6b 11.68%
unlock
, the lowest is
A$10.5b 1.20%
unlock
.

This results in the following potential growth metrics:

Revenue Estimates

2025 A$9.6b 7.56%
2026
A$11.0b 13.87%
unlock
2027
A$11.2b 2.13%
unlock
2028
A$11.7b 3.92%
unlock
2029
A$12.2b 4.67%
unlock
2030
A$13.0b 6.86%
unlock
2031
A$13.6b 4.46%
unlock
2032
A$14.2b 4.46%
unlock
2033
A$14.9b 4.46%
unlock

17 Analysts have issued an Sonic Healthcare EBITDA forecast 2026. The average Sonic Healthcare EBITDA estimate is

A$1.9b
unlock
. This is
6.20% higher
unlock
than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is
A$2.1b 13.00%
unlock
, the lowest is
A$1.8b 0.55%
unlock
.

This results in the following potential growth metrics and future EBITDA Margins:

EBITDA Estimates

2025 A$1.7b 7.36%
2026
A$1.9b 10.84%
unlock
2027
A$2.0b 2.74%
unlock
2028
A$2.1b 5.68%
unlock
2029
A$2.2b 3.76%
unlock
2030
A$2.8b 26.09%
unlock
2031
A$2.9b 4.91%
unlock
2032
A$3.0b 4.92%
unlock
2033
A$3.2b 4.69%
unlock

EBITDA Margin

2025 18.11% 0.18%
2026
17.63% 2.65%
unlock
2027
17.73% 0.57%
unlock
2028
18.03% 1.69%
unlock
2029
17.88% 0.83%
unlock
2030
21.09% 17.95%
unlock
2031
21.18% 0.43%
unlock
2032
21.28% 0.47%
unlock
2033
21.32% 0.19%
unlock

17 Sonic Healthcare Analysts have issued a net profit forecast 2026. The average Sonic Healthcare net profit estimate is

A$601m
unlock
. This is
11.42% higher
unlock
than the net profit for the last 12 months(TTM). The highest net profit forecast is
A$670m 24.17%
unlock
, the lowest is
A$557m 3.23%
unlock
.

This results in the following potential growth metrics and future Net Margins:

Net Profit Estimates

2025 A$514m 0.49%
2026
A$601m 17.01%
unlock
2027
A$613m 1.95%
unlock
2028
A$662m 7.98%
unlock
2029
A$714m 7.96%
unlock
2030
A$973m 36.19%
unlock
2031
A$1.0b 6.25%
unlock
2032
A$1.1b 5.89%
unlock
2033
A$1.2b 5.55%
unlock

Net Margin

2025 5.32% 6.57%
2026
5.47% 2.73%
unlock
2027
5.46% 0.18%
unlock
2028
5.68% 4.03%
unlock
2029
5.85% 2.99%
unlock
2030
7.46% 27.52%
unlock
2031
7.59% 1.74%
unlock
2032
7.69% 1.32%
unlock
2033
7.77% 1.04%
unlock

Earnings per share, P/E ratio and EV/sales Estimates 2026, 2027 to 2033

Create a premium account to unlock analyst estimates. Learn more

Select at least one metric to display the chart.


Jun '25 2026
Estimates
Earnings Per Share A$ 1.07 1.22
0.00% 14.02%
P/E 16.06
EV/Sales 1.36

17 Analysts have issued a Sonic Healthcare forecast for earnings per share. The average Sonic Healthcare EPS is

A$1.22
unlock
. This is
9.91% higher
unlock
than earnings per share in the financial year 2025. The highest EPS forecast is
A$1.36 22.52%
unlock
, the lowest is
A$1.13 1.80%
unlock
.

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2025 A$1.07 0.00%
2026
A$1.22 14.02%
unlock
2027
A$1.24 1.64%
unlock
2028
A$1.34 8.06%
unlock
2029
A$1.45 8.21%
unlock
2030
A$1.97 35.86%
unlock
2031
A$2.09 6.09%
unlock
2032
A$2.21 5.74%
unlock
2033
A$2.34 5.88%
unlock

P/E ratio

Current 17.68 21.79%
2026
16.06 8.77%
unlock
2027
15.76 1.87%
unlock
2028
14.59 7.42%
unlock
2029
13.52 7.33%
unlock
2030
9.92 26.63%
unlock
2031
9.34 5.85%
unlock
2032
8.82 5.57%
unlock
2033
8.36 5.22%
unlock

Based on analysts' sales estimates for 2026, the Sonic Healthcare stock is valued at an EV/Sales of

and an P/S ratio of .

This results in the following potential growth metrics and future valuations:

EV/Sales

Current 1.44 32.11%
2026
1.36 5.43%
unlock
2027
1.33 2.09%
unlock
2028
1.28 3.77%
unlock
2029
1.23 4.47%
unlock
2030
1.15 6.41%
unlock
2031
1.10 4.27%
unlock
2032
1.05 4.26%
unlock
2033
1.01 4.28%
unlock

P/S ratio

Current 0.93 19.53%
2026
0.87 5.11%
unlock
2027
0.85 2.08%
unlock
2028
0.82 3.78%
unlock
2029
0.78 4.46%
unlock
2030
0.73 6.42%
unlock
2031
0.70 4.27%
unlock
2032
0.67 4.27%
unlock
2033
0.64 4.27%
unlock

Current Sonic Healthcare Upgrades & Downgrades

Create a Premium account to unlock Upgrades/Downgrades. Learn more
Analyst Rating Action Date
BELL POTTER SECURITIES
Locked
Locked
Locked Jul 01 2026
MACQUARIE RESEARCH
Locked
Locked
Locked Jun 18 2026
JEFFERIES
Locked
Locked
Locked Jun 16 2026
JEFFERIES
Locked
Locked
Locked Jan 22 2026
JEFFERIES
Locked
Locked
Locked Jan 21 2026
BELL POTTER SECURITIES
Locked
Locked
Locked Nov 30 2025
MACQUARIE RESEARCH
Locked
Locked
Locked Nov 25 2025
Analyst Rating Date
Locked
BELL POTTER SECURITIES:
Locked
Locked
Jul 01 2026
Locked
MACQUARIE RESEARCH:
Locked
Locked
Jun 18 2026
Locked
JEFFERIES:
Locked
Locked
Jun 16 2026
Locked
JEFFERIES:
Locked
Locked
Jan 22 2026
Locked
JEFFERIES:
Locked
Locked
Jan 21 2026
Locked
BELL POTTER SECURITIES:
Locked
Locked
Nov 30 2025
Locked
MACQUARIE RESEARCH:
Locked
Locked
Nov 25 2025

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today